Geovax Inc Careers in Smyrna, GA

GeoVax (OTCQB: GOVX ) is a biotechnology company specializing in the creation, development, and commercialization of human vaccines to combat HIV/AIDS. Designed for predominant HIV virus subtypes in the developed world, our most advanced vaccine candidate is designed for use in uninfected people to protect them from AIDS should they be exposed to the HIV-1 virus. GeoVax’s preventive vaccine recently completed Phase 1 safety trials through the US Government sponsored HIV Vaccine Trials Network (HVTN) and is expected to begin Phase 2 testing during 2014. Results from preclinical studies have also demonstrated the therapeutic potential for our vaccine. A Phase 1 human clinical trial is now underway where the vaccine is being tested as a supplemental treatment for people already infected with HIV. As a leader in our field, we are committed to progress against the most devastating global disease of our lifetime. Specialties HIV/AIDS vaccine development